scholarly journals Feasibility and Short-Term Outcomes of Percutaneous Transcatheter Pulmonary Valve Replacement in Small (<30 kg) Children With Dysfunctional Right Ventricular Outflow Tract Conduits

2014 ◽  
Vol 7 (2) ◽  
pp. 142-148 ◽  
Author(s):  
Darren P. Berman ◽  
Doff B. McElhinney ◽  
Julie A. Vincent ◽  
William E. Hellenbrand ◽  
Evan M. Zahn
2022 ◽  
Vol 23 (2) ◽  
pp. 723
Author(s):  
Zhang Xiling ◽  
Thomas Puehler ◽  
Jette Seiler ◽  
Stanislav N. Gorb ◽  
Janarthanan Sathananthan ◽  
...  

Patients with the complex congenital heart disease (CHD) are usually associated with right ventricular outflow tract dysfunction and typically require multiple surgical interventions during their lives to relieve the right ventricular outflow tract abnormality. Transcatheter pulmonary valve replacement was used as a non-surgical, less invasive alternative treatment for right ventricular outflow tract dysfunction and has been rapidly developing over the past years. Despite the current favorable results of transcatheter pulmonary valve replacement, many patients eligible for pulmonary valve replacement are still not candidates for transcatheter pulmonary valve replacement. Therefore, one of the significant future challenges is to expand transcatheter pulmonary valve replacement to a broader patient population. This review describes the limitations and problems of existing techniques and focuses on decellularized tissue engineering for pulmonary valve stenting.


Sign in / Sign up

Export Citation Format

Share Document